Sheaff Brock Investment Advisors’s GSK GSK Stock Holding History

Sheaff Brock Investment Advisors’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-4,594	Closed	-$233K	–	542
2017 Q3	$233K	Buy	4,594 +10	+0.2%	+$507	0.03%	431
2017 Q2	$247K	Sell	4,584 -307	-6%	-$16.4K	0.03%	441
2017 Q1	$258K	Sell	4,891 -5,599	-53%	-$284K	0.03%	436
2016 Q4	$505K	Buy	10,490 +5,011	+91%	+$248K	0.06%	285
2016 Q3	$295K	Sell	5,479 -828	-13%	-$45.4K	0.04%	358
2016 Q2	$342K	Sell	6,307 -935	-13%	-$49.3K	0.04%	344
2016 Q1	$367K	Buy	7,242 +641	+10%	+$31.9K	0.05%	343
2015 Q4	$333K	Buy	+6,601	New	+$336K	0.04%	384

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Sheaff Brock Investment Advisors's GSK Position: Q4 2017 in Review

Sheaff Brock Investment Advisors sold out of GSK (GSK) in Q4 2017, closing a stake of 4,594 shares — an estimated $233K sold.

Sheaff Brock Investment Advisors first reported a position in GSK in Q4 2015 and held it in 8 quarters. The position peaked at $505K in Q4 2016. 763 funds tracked by Wall St. Rank hold GSK as of Q4 2017.

Sheaff Brock Investment Advisors reported no remaining GSK position as of Q4 2017 after selling out during the quarter.
Sheaff Brock Investment Advisors sold 4,594 GSK shares in Q4 2017, an estimated $233K.
Sheaff Brock Investment Advisors first reported a position in GSK in Q4 2015 and held it in 8 quarters.
Sheaff Brock Investment Advisors's GSK position peaked at $505K in Q4 2016.
763 funds tracked by Wall St. Rank held GSK as of Q4 2017.

Based on Sheaff Brock Investment Advisors's 13F filing for Q4 2017, filed 12 Feb 2018.